12 Nov 2020
Initial study results show feasibility of outpatient methotrexate administration with planned-use Voraxaze® (glucarpidase) during COVID-19 pandemic
BTG Specialty Pharmaceuticals highlights study inspired by COVID-19 pandemic conditions, presented at Society for NeuroOncology annual conference
